The Food and Drug Administration has long made clear that social-media remarks touting medical products can violate the law, so it quickly issued a warning recently when Kim Kardashian praised and endorsed her morning-sickness drug on Instagram.
Last month, Kardashian posted about a morning sickness drug called Diclegis, made by a drug company called Duchesnay. “OMG. Have you heard about this? As you guys know my #morningsickness has been pretty bad. I tried changing things about my lifestyle, like my diet, but nothing helped, so I talked to my doctor.
He prescribed me #Diclegis, and I felt a lot better and most importantly, it’s been studied and there was no increased risk to the baby. I’m so excited and happy with my results that I’m partnering with Duchesnay USA to raise awareness about treating morning sickness. If you have morning sickness, be safe and sure to ask your doctor about the pill with the pregnant woman on it and find out more www.diclegis.com;
www.DiclegisImportantSafetyInfo.com.” the celebrity wrote on an Instagram post that she also linked to on Twitter late last month. Kardashian has more than 34 million Twitter followers and 42 million Instagram followers.
The Food and Drug Administration struck back against Ms. Kardashian’s post, issuing a warning letter (which it made public this week) to the drug’s maker, Duchesnay Inc., that said the post failed to give information about the drug’s risks. The letter ordered the company to “immediately cease misbranding.”
The FDA now calls Kardashian’s posts “false and misleading” because they omitted “all risk information.” Her post, which garnered 460,000 likes, “misleadingly fails to provide material information about the consequences that may result from the use of the drug and suggests that it is safer than has been demonstrated,” according to the letter.
..... Devashree Goenka